Zenas BioPharma, Inc. (ZBIO) stock
ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$26.42−1.33 (-4.79%)
Close on Nov 18, 2026Market cap $1.72BP/E –Yield –
Zenas BioPharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Zenas BioPharma's revenue for the twelve months ending Dec 31, 2025 was $10.00M, up 100.0% year over year. For fiscal 2025 it was $10.00M, up 100.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.00M | +100.0% |
| FY2024 | Dec 31, 2024 | $5.00M | -90.0% |
| FY2023 | Dec 31, 2023 | $50.00M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $10.00M | – |
| Q2 FY2026 | Jun 30, 2026 | $1.00M | -90.0% |
| Q4 FY2025 | Dec 31, 2025 | $0 | -100.0% |
| Q3 FY2025 | Sep 30, 2025 | $0 | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
| Q1 FY2025 | Mar 31, 2025 | $10.00M | – |
| Q4 FY2024 | Dec 31, 2024 | $5.00M | -90.0% |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024 | Jun 30, 2024 | $0 | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $50.00M | – |
See a number that looks wrong?